Pipeline

Code Name		Stage							Indication
Code Name		Discovery	Lead Optimization	Pre-clinical	Phase I	Phase II	Phase III	NDA	Indication
Biologics	BMI2006								Glabellar Lines
	BMI2004								Increased Drug Penetration during SC Administration
	mRNA Vaccine								Prevention of COVID-19
	BMI2007								Prevention of Herpes Zoster
Pharmaceuticals	BMI1001								Hemostatic
Pharmaceuticals	BMI1018								Osteoarthritis
Medical Devices	BMI4001								Nasolabial Fold
	BMI4005								Osteoarthritis
	BMI4006								Biomaterials for Tissue Repair
	BMI4008								Absorbable Wound Dressing
Cosmetics	BMI6005								Skin Moisturizing
Cosmetics	BMI6006								Skin Moisturizing

Current progress

R & D